ISOP_Logo_Final
+1-908-253-3608
info@go-isop.org
Facebook
Twitter
LinkedIn
YouTube
  • About ISoP
    • Constitution and By-laws
    • Five-Year Strategic Plan
    • Leadership Team
    • Awards
    • Member Spotlight
    • General Members’ Meetings
    • Logo Usage Policies
    • Communications Guidelines
    • Memorial Policy
    • discuss.go-isop.org
    • Photo Gallery (Flickr)
    • Contact Us
  • Events
    • ACoP
    • PAGE
    • WCoP
    • AAPS
    • ACCP
    • ASCPT
    • PAGANZ
    • PAGJA
    • Pharmacometrics Network Benelux
    • PKUK
    • RedIF
    • SUP
  • Membership
    • Member Profile
    • Join
    • Renew
    • Volunteer
  • Training Material
    • Tutorials
    • ISoP YouTube Channel
    • Shiny Server
    • Resources
  • SIGs
    • Clinical Pharmacometrics
    • Mathematical and Computational Sciences (MCS)
    • Quantitative Systems Pharmacology (QSP)
    • Statistics and Pharmacometrics (SxP)
  • Committees
    • Awards Committee
    • Communications Committee
    • Conference Committee
    • Education Committee
    • Executive Committee
    • Finance Committee
    • Membership Committee
    • Nominations Committee
    • Scientific Partnership Committee
    • Standards & Best Practices Committee
    • Technology Committee
  • Student Community
  • Local Groups
    • Midwest
    • New England
    • NJ/PA/NY
  • Official Journals
    • Recent Publications
    • Newsletters
  • Career Center
  • Volunteer!

Influence

Home Five-Year Strategic Plan Influence

Board representative: Heather Vezina

Objective: To enable the use of pharmacometrics to inform decision making within drug discovery, development and clinical practice.

Initial priority will be placed on development of a communications package designed to describe the science of pharmacometrics to external audiences and communities. In parallel to this, the working group will identify key stakeholders for increased engagement over the next 3-5 years. Engagement with the identified stakeholders, such as clinical societies, regulatory agencies, and healthcare payer organizations, is prioritized to first deeply understand their perspective, followed by a systematic and sustainable engagement with those areas. 

Five-year goals

  • By 2023, key stakeholders including regulators, clinicians and other technical disciplines have a robust understanding of the value of pharmacometrics for quantitative decision making.
  • In the 1-2 therapeutic areas that have been prioritized for engagement, pharmacometrics is embraced as a core discipline in modern drug development, and is more routinely observed in clinical journals and meetings, thus enabling sustainable contributions beyond this strategic plan.
  • By 2023 ISoP has leveraged these experiences to develop a playbook for engaging with additional therapeutic areas following this strategic plan.

Want to help? Volunteer!

     

What’s New

  • Happy 10th Birthday ISoP! April 2, 2021
  • 2021 Membership Drive February 4, 2021
  • ISoP Mentorship Program January 26, 2021

ISoP Membership

  • Join Now
  • Benefits
Copyright 2021 by ISoP
Privacy Statement

International Society of Pharmacometrics
1200 Rt 22E Suite 2000
Bridgewater, NJ 08807
United States

+1-908-253-3608
info@go-isop.org
@ISoP1